Go Deep
Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -17,592 | -1.1 | -5.19 | -0.91 | 670.58 |
| Oct 2026 | -17,587 | -1.0 | -5.18 | -0.91 | 669.63 |
| Oct 2026 | -19,270 | -1.0 | -4.96 | -0.91 | 641.91 |
| Oct 2026 | -19,301 | -1.0 | -5.00 | -0.91 | 646.65 |
| Oct 2026 | -19,143 | -1.0 | -4.72 | -0.91 | 609.12 |
| Oct 2026 | -19,346 | -1.0 | -4.99 | -0.91 | 642.80 |
Tevogen Bio Holdings Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -5,761,940.0 | -5,446,255.0 | -4,677,580.0 | -5,726,812.0 |
| EPS | -1.5 | -1.6 | — | -1.5 |
Tevogen Bio Holdings Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -26,275,432.0 | -13,727,380.0 | -60,477,680.0 | 4,408,361.0 | — |
| EPS | -8.1 | -3.5 | -19.1 | 1.8 | — |
Tevogen Bio Holdings Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 4,382,994.0 | 3,461,675.0 | 5,505,503.0 | 357,138,356.0 |
| Total Liabilities | 12,617,720.0 | 10,135,680.0 | 99,934,400.0 | 15,057,704.0 |
| Total Equity | -8,234,726.0 | -6,674,005.0 | -94,428,897.0 | 342,080,652.0 |
Owes vs Owns
Tevogen Bio Holdings Inc. owed $2.88 for every $1 it owned in Jun 2026, up from $0.04 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 2.88× | 2.88× | 2.93× | 18.2× | 0.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Tevogen Bio Holdings Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 12.6%Receivables 3.6%Fixed assets (tangible) 36.4%Other assets 47.4%
How it's funded — Dec 2025
Short-term debt 13.1%Long-term debt 34.9%Payables 26.5%Other liabilities 25.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.6 | 1.3 | 1.1 | 0.1 |
| Receivables | 0.2 | 0.2 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 1.6 | 0.5 | 0.9 | 1.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 2.1 | 1.5 | 3.5 | 355.7 |
| Liabilities & equity | ||||
| Short-term debt | 1.7 | 1.7 | 80.7 | 0.3 |
| Long-term debt | 4.4 | 1.0 | 14.2 | 39.3 |
| Payables | 3.3 | 5.2 | 3.4 | 0.2 |
| Other liabilities | 3.2 | 2.3 | 1.6 | 0.0 |
| Shareholders' equity | -8.2 | -6.7 | -94.4 | 342.1 |
| Net tangible assets | -8.2 | -6.7 | -94.4 | 342.1 |
Tevogen Bio Holdings Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -12,328,577.0 | -11,998,730.0 | -8,171,118.0 | -215,395.0 | — |
| Investing Activities | -64,439.0 | 0.0 | -133,000.0 | 0.0 | — |
| Financing Activities | 11,662,393.0 | 12,229,328.0 | 3,872,250.0 | 0.0 | — |